Inhibition of chondroitin sulfate proteoglycans enhances cell migration following enteric neural stem cell transplantation
Development · 2026
DOI: 10.1242/dev.205625 ↗At a glance
Journal article in Development, 2026. Written by Emőke Szőcs and 8 co-authors. Institution: Department of Anatomy, Histology and Embryology, Faculty of Medicine, Semmelweis University, Budapest 1094, Hungary. Major MEDLINE topics: Cell Movement, Neural Stem Cells, Chondroitin Sulfate Proteoglycans, Enteric Nervous System. Cited 1 times so far (Crossref); 59 references. Funded by: Semmelweis Egyetem, Hungarian Science Foundation, Ministry of Culture and Innovation.
Abstract (original language)
Enteric nervous system development relies on migration, proliferation and differentiation of enteric neural crest-derived cells (ENCDCs), processes that are regulated by mesenchymal morphogens and the extracellular matrix (ECM). Hirschsprung disease (HD) is a congenital neurocristopathy in which abnormal gut motility results from loss of ENCDC-derived enteric ganglia in the colorectum. While enteric neural stem cell transplantation is a proposed therapy, current efforts are limited by poor cell migration in HD models. To address this, we investigated ECM-derived inhibitory cues on enteric neural stem cell transplantation efficiency. Immunohistochemistry of embryonic chick hindgut reveals dynamic chondroitin sulfate proteoglycan (CSPG) expression during development. In vitro assays show that CSPGs inhibit ENCDC migration, an effect reversed by chondroitinase ABC. Transplantation of enteric neurospheres into chick and mouse colon results in limited engraftment, but chondroitinase ABC significantly enhances migration of transplanted cells. Single-cell RNA sequencing of postnatal mouse neurospheres reveals high expression of CD44, a transmembrane glycoprotein that can act as a functional CSPG on the cell surface. Blocking CD44 function promotes neurosphere-derived ENCDC migration. Modulating inhibitory ECM components may enhance the success of regenerative therapies for HD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Anatomy, Histology and Embryology, Faculty of Medicine, Semmelweis University, Budapest 1094, Hungary.
- Department of Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
ORCID profiles: Emőke Szőcs, Réka Borbála Tóth, Nándor Nagy
Funding
- Semmelweis Egyetem
- Hungarian Science Foundation
- Ministry of Culture and Innovation
- National Biomedical Foundation
- NIH HHS
- National Institutes of Health
Cite
APA
Szőcs, E., Mueller, J. L., Jurenka, C., Tóth, R. B., Halasy, V., Hotta, R., Soós, Á., Goldstein, A. M., & Nagy, N. (2026). Inhibition of chondroitin sulfate proteoglycans enhances cell migration following enteric neural stem cell transplantation. Development. https://doi.org/10.1242/dev.205625
Vancouver
Szőcs E, Mueller JL, Jurenka C, Tóth RB, Halasy V, Hotta R, et al. Inhibition of chondroitin sulfate proteoglycans enhances cell migration following enteric neural stem cell transplantation. Development. 2026. doi:10.1242/dev.205625
BibTeX
@article{Szcs2026,
author = {Szőcs, Emőke and Mueller, Jessica L and Jurenka, Csenge and Tóth, Réka Borbála and Halasy, Viktória and Hotta, Ryo and Soós, Ádám and Goldstein, Allan M and Nagy, Nándor},
title = {Inhibition of chondroitin sulfate proteoglycans enhances cell migration following enteric neural stem cell transplantation},
journal = {Development},
year = {2026},
doi = {10.1242/dev.205625}
}
EUVIMED